ProtoKinetix, Inc. (PKTX)
ProtoKinetix, Incorporated is a biotechnology firm engaged in research and development, specializing in the scientific and medical investigation of glycoproteins known as anti-freeze glycoproteins (AFGPs) and anti-aging glycoproteins (AAGPs). These AFGPs are particularly relevant for their commercial potential within the healthcare sector, with a key area of their development involving utilizing AAGPs for the treatment of dry-eye conditions. Their research efforts are bolstered by a collaborative agreement with the University of British Columbia. Originally incorporated in 1999 as RJV Network, Inc., the company adopted its current name, ProtoKinetix, Incorporated, in July 2003. Its operational headquarters are situated in Marietta, Ohio.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
ProtoKinetix, Incorporated
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 411.63M shares outstanding
USProtoKinetix, Incorporated is a biotechnology firm engaged in research and development, specializing in the scientific and medical investigation of glycoproteins known as anti-freeze glycoproteins (AFGPs) and anti-aging glycoproteins (AAGPs). These AFGPs are particularly relevant for their commercial potential within the healthcare sector, with a key area of their development involving utilizing AAGPs for the treatment of dry-eye conditions. Their research efforts are bolstered by a collaborative agreement with the University of British Columbia. Originally incorporated in 1999 as RJV Network, Inc., the company adopted its current name, ProtoKinetix, Incorporated, in July 2003.
Its operational headquarters are situated in Marietta, Ohio.
Leadership
Dr. Julia Levy
Chairman, Business and Scientific Advisory Board
Michael Richard Guzzetta
Chairman, CEO, CFO, Treasurer & Secretary
Keith R. Brunt
President & Director
Employees
5
Country
US
Sector
Healthcare
Website
protokinetix.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 SMITH CLARENCE EDWARD | President & CEO | Purchase | 2.00M | $20.0K | Sep 26, 2024 |
| Name | Shares | % | Source |
|---|---|---|---|
 SMITH CLARENCE EDWARD President & CEO, Director, 10% Owner | 70.2M | 17.1% | FORM 4 |
 Lamp Jason G. Director | 6.5M | 1.6% | FORM 4 |
 Jones Michael Winston Director | 6.4M | 1.6% | FORM 4 |
 Brunt Keith R. President, Director | 2.0M | 0.5% | FORM 4 |
Williams Jones Wealth Management, LLC. | 20.0K | 0.0% | 13F |
Insiders
- SMITH CLARENCE EDWARDPresident & CEO
- Lamp Jason G.Director
- Jones Michael WinstonDirector
- Brunt Keith R.President, Director
Top institutional holders
based on 411.63M shares outstanding
US30d Avg
190.03K
60d Avg
110.19K
90d Avg
130.43K